Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome.

Klompenhouwer AJ, Dwarkasing RS, Doukas M, Pellegrino S, Vilgrain V, Paradis V, Soubrane O, Beane JD, Geller DA, Nalesnik MA, Tripke V, Lang H, Schmelzle M, Pratschke J, Schöning W, Beal E, Sun S, Pawlik TM, de Man RA, Ijzermans JNM.

HPB (Oxford). 2019 Oct 13. pii: S1365-182X(19)30716-6. doi: 10.1016/j.hpb.2019.09.004. [Epub ahead of print]

PMID:
31619346
2.

Donors with central nervous system cancer: Proceed with vigilance.

Nalesnik MA.

Transplantation. 2019 Oct 7. doi: 10.1097/TP.0000000000002995. [Epub ahead of print] No abstract available.

PMID:
31596741
3.

Surgical Management of Ciliated Hepatic Foregut Cyst.

Ziogas IA, van der Windt DJ, Wilson GC, Furlan A, Nalesnik MA, Tohme S, Geller DA.

Hepatology. 2019 Jul 25. doi: 10.1002/hep.30877. [Epub ahead of print] No abstract available.

PMID:
31344277
4.

Renal cell carcinoma suspected at time of organ donation 2008-2016: A report of the OPTN ad hoc Disease Transmission Advisory Committee Registry.

Pavlakis M, Michaels MG, Tlusty S, Turgeon N, Vece G, Wolfe C, Wood RP, Nalesnik MA.

Clin Transplant. 2019 Jul;33(7):e13597. doi: 10.1111/ctr.13597. Epub 2019 Jun 25.

PMID:
31104323
5.

Hepatic Angiosarcoma: A Multi-institutional, International Experience with 44 Cases.

Wilson GC, Lluis N, Nalesnik MA, Nassar A, Serrano T, Ramos E, Torbenson M, Asbun HJ, Geller DA.

Ann Surg Oncol. 2019 Feb;26(2):576-582. doi: 10.1245/s10434-018-7062-9. Epub 2018 Nov 19.

PMID:
30456677
6.

Circular DNA tumor viruses make circular RNAs.

Toptan T, Abere B, Nalesnik MA, Swerdlow SH, Ranganathan S, Lee N, Shair KH, Moore PS, Chang Y.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8737-E8745. doi: 10.1073/pnas.1811728115. Epub 2018 Aug 27.

7.

Augmenter of liver regeneration: A fundamental life protein.

Nalesnik MA, Gandhi CR, Starzl TE.

Hepatology. 2017 Jul;66(1):266-270. doi: 10.1002/hep.29047. Epub 2017 May 22. Review. No abstract available.

8.

Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients.

Ezzelarab MB, Zhang H, Guo H, Lu L, Zahorchak AF, Wiseman RW, Nalesnik MA, Bhama JK, Cooper DK, Thomson AW.

Am J Transplant. 2016 Jul;16(7):1999-2015. doi: 10.1111/ajt.13685. Epub 2016 Mar 17.

9.

Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee.

Green M, Covington S, Taranto S, Wolfe C, Bell W, Biggins SW, Conti D, DeStefano GD, Dominguez E, Ennis D, Gross T, Klassen-Fischer M, Kotton C, LaPointe-Rudow D, Law Y, Ludrosky K, Menegus M, Morris MI, Nalesnik MA, Pavlakis M, Pruett T, Sifri C, Kaul D.

Transplantation. 2015 Feb;99(2):282-7. doi: 10.1097/TP.0000000000000584.

PMID:
25594557
10.

Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice.

Gandhi CR, Chaillet JR, Nalesnik MA, Kumar S, Dangi A, Demetris AJ, Ferrell R, Wu T, Divanovic S, Stankeiwicz T, Shaffer B, Stolz DB, Harvey SA, Wang J, Starzl TE.

Gastroenterology. 2015 Feb;148(2):379-391.e4. doi: 10.1053/j.gastro.2014.10.008. Epub 2014 Oct 13.

11.

Communication gaps associated with donor-derived infections.

Miller R, Covington S, Taranto S, Carrico R, Ehsan A, Friedman B, Green M, Ison MG, Kaul D, Kubak B, Lebovitz DJ, Lyon GM, Nalesnik MA, Pruett TL, Teperman L, Vasudev B, Blumberg E.

Am J Transplant. 2015 Jan;15(1):259-64. doi: 10.1111/ajt.12978. Epub 2014 Nov 6.

12.

Acute liver allograft antibody-mediated rejection: an inter-institutional study of significant histopathological features.

O'Leary JG, Michelle Shiller S, Bellamy C, Nalesnik MA, Kaneku H, Jennings LW, Isse K, Terasaki PI, Klintmalm GB, Demetris AJ.

Liver Transpl. 2014 Oct;20(10):1244-55. doi: 10.1002/lt.23948.

13.

Cancers among US organ donors: a comparison of transplant and cancer registry diagnoses.

Engels EA, Castenson D, Pfeiffer RM, Kahn A, Pawlish K, Goodman MT, Nalesnik MA, Israni AK, Snyder J, Kasiske B.

Am J Transplant. 2014 Jun;14(6):1376-82. doi: 10.1111/ajt.12683. Epub 2014 Apr 8.

14.

Neuroendocrine carcinoma of the extrahepatic bile duct: case report and literature review.

Sasatomi E, Nalesnik MA, Marsh JW.

World J Gastroenterol. 2013 Jul 28;19(28):4616-23. doi: 10.3748/wjg.v19.i28.4616. Review.

15.

Plasma cell tumors in transplant patients.

Nalesnik MA.

Blood. 2013 Feb 21;121(8):1247-9. doi: 10.1182/blood-2013-01-475947.

PMID:
23429983
16.

Despite the best intentions cancer is transmissible by transplantation.

Chapman JR, Nalesnik MA.

Transplantation. 2012 Dec 27;94(12):1185-6. doi: 10.1097/TP.0b013e3182762dd0. No abstract available.

PMID:
23149478
17.

Growth factor pathways in development and progression of hepatocellular carcinoma.

Nalesnik MA, Michalopoulos GK.

Front Biosci (Schol Ed). 2012 Jun 1;4:1487-515. Review.

PMID:
22652888
18.

Gene deletions and amplifications in human hepatocellular carcinomas: correlation with hepatocyte growth regulation.

Nalesnik MA, Tseng G, Ding Y, Xiang GS, Zheng ZL, Yu Y, Marsh JW, Michalopoulos GK, Luo JH.

Am J Pathol. 2012 Apr;180(4):1495-508. doi: 10.1016/j.ajpath.2011.12.021. Epub 2012 Feb 8.

19.

The loss of renal dendritic cells and activation of host adaptive immunity are long-term effects of ischemia/reperfusion injury following syngeneic kidney transplantation.

Ozaki KS, Kimura S, Nalesnik MA, Sico RM, Zhang M, Ueki S, Ross MA, Stolz DB, Murase N.

Kidney Int. 2012 May;81(10):1015-1025. doi: 10.1038/ki.2011.458. Epub 2012 Jan 25.

20.

Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring?

Lunz J, Ruppert KM, Cajaiba MM, Isse K, Bentlejewski CA, Minervini M, Nalesnik MA, Randhawa P, Rubin E, Sasatomi E, de Vera ME, Fontes P, Humar A, Zeevi A, Demetris AJ.

Am J Transplant. 2012 Jan;12(1):171-82. doi: 10.1111/j.1600-6143.2011.03786.x. Epub 2011 Oct 12.

21.

Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.

Nalesnik MA, Woodle ES, Dimaio JM, Vasudev B, Teperman LW, Covington S, Taranto S, Gockerman JP, Shapiro R, Sharma V, Swinnen LJ, Yoshida A, Ison MG.

Am J Transplant. 2011 Jun;11(6):1140-7. doi: 10.1111/j.1600-6143.2011.03565.x.

22.

EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?

Gibson SE, Swerdlow SH, Craig FE, Surti U, Cook JR, Nalesnik MA, Lowe C, Wood KM, Bacon CM.

Am J Surg Pathol. 2011 Jun;35(6):807-15. doi: 10.1097/PAS.0b013e3182190999.

PMID:
21552113
23.

An update on donor-derived disease transmission in organ transplantation.

Ison MG, Nalesnik MA.

Am J Transplant. 2011 Jun;11(6):1123-30. doi: 10.1111/j.1600-6143.2011.03493.x. Epub 2011 Mar 28. Review.

24.

Spontaneous rupture of hepatic artery aneurysm associated with polyarteritis nodosa.

Parent BA, Cho SW, Buck DG, Nalesnik MA, Gamblin TC.

Am Surg. 2010 Dec;76(12):1416-9. Review.

PMID:
21265359
25.

Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.

Ragni MV, Moore CG, Soadwa K, Nalesnik MA, Zajko AB, Cortese-Hassett A, Whiteside TL, Hart S, Zeevi A, Li J, Shaikh OS; HHH Study Group.

Haemophilia. 2011 Jan;17(1):103-11. doi: 10.1111/j.1365-2516.2010.02366.x. Epub 2010 Aug 16.

26.

Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.

Pomfret EA, Washburn K, Wald C, Nalesnik MA, Douglas D, Russo M, Roberts J, Reich DJ, Schwartz ME, Mieles L, Lee FT, Florman S, Yao F, Harper A, Edwards E, Freeman R, Lake J.

Liver Transpl. 2010 Mar;16(3):262-78. doi: 10.1002/lt.21999.

27.

Ex vivo application of carbon monoxide in UW solution prevents transplant-induced renal ischemia/reperfusion injury in pigs.

Yoshida J, Ozaki KS, Nalesnik MA, Ueki S, Castillo-Rama M, Faleo G, Ezzelarab M, Nakao A, Ekser B, Echeverri GJ, Ross MA, Stolz DB, Murase N.

Am J Transplant. 2010 Apr;10(4):763-72. doi: 10.1111/j.1600-6143.2010.03040.x. Epub 2010 Feb 25.

28.

Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks.

Abu-Elmagd KM, Mazariegos G, Costa G, Soltys K, Bond G, Sindhi R, Green M, Jaffe R, Wu T, Koritsky D, Matarese L, Schuster B, Martin L, Dvorchik I, Nalesnik MA.

Transplantation. 2009 Oct 15;88(7):926-34. doi: 10.1097/TP.0b013e3181b7509c.

PMID:
19935465
29.

Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.

Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, Fernández-Figueras MT, Tolstov Y, Gjoerup O, Mansukhani MM, Swerdlow SH, Chaudhary PM, Kirkwood JM, Nalesnik MA, Kant JA, Weiss LM, Moore PS, Chang Y.

Int J Cancer. 2009 Sep 15;125(6):1243-9. doi: 10.1002/ijc.24510.

30.

Low-dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft function.

Nakao A, Faleo G, Nalesnik MA, Seda-Neto J, Kohmoto J, Murase N.

Am J Physiol Renal Physiol. 2009 Jul;297(1):F19-26. doi: 10.1152/ajprenal.90728.2008. Epub 2009 Apr 15.

31.

Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection.

Ragni MV, Nalesnik MA, Schillo R, Dang Q.

Haemophilia. 2009 Mar;15(2):552-8.

32.

Multiple hepatic adenomas associated with liver steatosis at CT and MRI: a case-control study.

Furlan A, van der Windt DJ, Nalesnik MA, Sholosh B, Ngan KK, Pealer KM, Ijzermans JN, Federle MP.

AJR Am J Roentgenol. 2008 Nov;191(5):1430-5. doi: 10.2214/AJR.07.3419.

PMID:
18941081
33.

Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma.

Nalesnik MA, Federle M, Buck D, Fontes P, Carr BI.

Hum Pathol. 2009 Jan;40(1):125-34. doi: 10.1016/j.humpath.2008.06.024. Epub 2008 Sep 16.

PMID:
18799190
34.

Expression of specific hepatocyte and cholangiocyte transcription factors in human liver disease and embryonic development.

Limaye PB, Alarcón G, Walls AL, Nalesnik MA, Michalopoulos GK, Demetris AJ, Ochoa ER.

Lab Invest. 2008 Aug;88(8):865-72. doi: 10.1038/labinvest.2008.56. Epub 2008 Jun 23.

35.

Unresectable hepatocellular carcinoma with a solitary metastasis to the mandible.

Li R, Walvekar RR, Nalesnik MA, Gamblin TC.

Am Surg. 2008 Apr;74(4):346-9.

PMID:
18453303
36.

Posttransplant adenoviral enteropathy in patients with small bowel transplantation.

Adeyi OA, Randhawa PA, Nalesnik MA, Ochoa ER, Abu-Elmagd KM, Demetris AJ, Wu T.

Arch Pathol Lab Med. 2008 Apr;132(4):703-5. doi: 10.1043/1543-2165(2008)132[703:PAEIPW]2.0.CO;2.

PMID:
18384224
37.

Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation.

Toyokawa H, Nakao A, Bailey RJ, Nalesnik MA, Kaizu T, Lemoine JL, Ikeda A, Tomiyama K, Papworth GD, Huang L, Demetris AJ, Starzl TE, Murase N.

Liver Transpl. 2008 Mar;14(3):346-57. doi: 10.1002/lt.21378.

38.

Carcinoid of the extra-hepatic bile duct: a case report with long-term follow-up and review of literature.

Gusani NJ, Marsh JW, Nalesnik MA, Tublin ME, Gamblin TC.

Am Surg. 2008 Jan;74(1):87-90. Review.

PMID:
18274439
39.

Altered liver morphology after portal vein thrombosis: not always cirrhosis.

Tublin ME, Towbin AJ, Federle MP, Nalesnik MA.

Dig Dis Sci. 2008 Oct;53(10):2784-8. doi: 10.1007/s10620-008-0201-6. Epub 2008 Feb 14.

PMID:
18270830
40.

Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders.

Craig FE, Johnson LR, Harvey SA, Nalesnik MA, Luo JH, Bhattacharya SD, Swerdlow SH.

Diagn Mol Pathol. 2007 Sep;16(3):158-68.

PMID:
17721324
41.

Alloimmune hepatitis following peripheral stem cell transplantation.

Habib S, Nalesnik MA, Ahmad J, BuchBarker D, Shakil AO.

Bone Marrow Transplant. 2007 May;39(9):573-5. Epub 2007 Mar 19. No abstract available.

PMID:
17369864
42.

Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.

Johnson LR, Nalesnik MA, Swerdlow SH.

Am J Surg Pathol. 2006 Dec;30(12):1604-12.

PMID:
17122518
43.

Histopathologic characteristics of human intestine allograft acute rejection in patients pretreated with thymoglobulin or alemtuzumab.

Wu T, Bond G, Martin D, Nalesnik MA, Demetris AJ, Abu-Elmagd K.

Am J Gastroenterol. 2006 Jul;101(7):1617-24.

PMID:
16863569
44.

Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injury.

Nakao A, Toyokawa H, Tsung A, Nalesnik MA, Stolz DB, Kohmoto J, Ikeda A, Tomiyama K, Harada T, Takahashi T, Yang R, Fink MP, Morita K, Choi AM, Murase N.

Am J Transplant. 2006 Oct;6(10):2243-55. Epub 2006 Jul 6.

45.

Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism.

Nakao A, Toyokawa H, Kimizuka K, Nalesnik MA, Nozaki I, Bailey RJ, Demetris AJ, Starzl TE, Murase N.

Blood. 2006 Aug 15;108(4):1413-20. Epub 2006 Apr 25.

46.

NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis.

Irie J, Wu Y, Wicker LS, Rainbow D, Nalesnik MA, Hirsch R, Peterson LB, Leung PS, Cheng C, Mackay IR, Gershwin ME, Ridgway WM.

J Exp Med. 2006 May 15;203(5):1209-19. Epub 2006 Apr 24.

47.

Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival.

Kaizu T, Ikeda A, Nakao A, Takahashi Y, Tsung A, Kohmoto J, Toyokawa H, Shao L, Bucher BT, Tomiyama K, Nalesnik MA, Murase N, Geller DA.

Hepatology. 2006 Mar;43(3):464-73.

PMID:
16496305
48.

Heart allograft protection with low-dose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive T-cell responses.

Nakao A, Toyokawa H, Abe M, Kiyomoto T, Nakahira K, Choi AM, Nalesnik MA, Thomson AW, Murase N.

Transplantation. 2006 Jan 27;81(2):220-30.

PMID:
16436966
49.

Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil.

Funch DP, Ko HH, Travasso J, Brady J, Kew CE 2nd, Nalesnik MA, Walker AM.

Transplantation. 2005 Nov 15;80(9):1174-80.

PMID:
16314782
50.

3D-confocal structural analysis of bone marrow-derived renal tubular cells during renal ischemia/reperfusion injury.

Toyokawa H, Nakao A, Stolz DB, Romanosky AJ, Nalesnik MA, Neto JS, Kaizu T, Demetris AJ, Murase N.

Lab Invest. 2006 Jan;86(1):72-82.

Supplemental Content

Loading ...
Support Center